HTA Database - Search Results

Sort by Relevance

Search Results [15931 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2014	Health Quality Ontario (HQO)	Physiotherapy after knee arthroscopy: a rapid review
2014	Health Quality Ontario (HQO)	Preoperative shower or bath with antiseptics before knee arthroscopy: a rapid review
2014	Health Quality Ontario (HQO)	Peripheral nerve blocks for post-operative pain relief after arthroscopic knee ligament reconstruction: a rapid review
2014	Health Quality Ontario (HQO)	Bracing after knee arthroscopy: a rapid review
2014	Health Quality Ontario (HQO)	Intra-articular analgesia after knee arthroscopy: a rapid review
2014	University of York	Evidence to inform urgent and emergency care systems
2014	University of York	Interventions for loneliness and social isolation
2014	University of York	Self-care support for people with COPD
2014	University of York	Predictive validity of tools used to assess the risk of unplanned admissions: A rapid review of the evidence.
2014	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Innovative medical devices for diabetes management - Update of Short report n. 6/2012
2014	NIHR Health Services and Delivery Research programme	Rethinking resistance to 'big IT': a sociological study of why and when healthcare staff do not use nationally mandated information and communication technologies
2014	NIHR Health Services and Delivery Research programme	Can valid and practical risk-prediction or casemix adjustment models, including adjustment for comorbidity, be generated from English hospital administrative data (Hospital Episode Statistics)? A national observational study
2014	NIHR Health Services and Delivery Research programme	The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST).
2014	NIHR Health Services and Delivery Research programme	Geographical and temporal understanding in place of death in England (1984–2010): analysis of trends and associated factors to improve end-of-life care (GUIDE_Care) – primary research
2014	NIHR Health Services and Delivery Research programme	What evidence is there for a relationship between organisational features and patient outcomes in congenital heart disease services? A rapid review
2014	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Neonatal screening for biotinidase deficiency]
2014	National Evidence-based Healthcare Collaborating Agency (NECA)	[Comparative effectiveness research of computer-assisted navigation in knee arthroplasty]
2014	Andalusian Health Technology Assessment Area (AETSA)	[Genetic diseases in Spain: map of genetic tests available in the national health system]
2014	Andalusian Health Technology Assessment Area (AETSA)	[Effectiveness, safety and efficiency of palivizumab for prevention of respiratory syncytial virus infection in premature infants]
2014	Norwegian Knowledge Centre for the Health Services (NOKC)	[End-of-life care - how to find the appropriate level and intensity of medical treatment of seriously ill and dying patients]
2014	Agency for Healthcare Research and Quality (AHRQ)	Negative pressure wound therapy technologies for chronic wound care in the home setting
2014	Agency for Healthcare Research and Quality (AHRQ)	Behavioral sexual risk reduction counseling in primary care to prevent sexually transmitted infections: an updated systematic evidence review for the U.S. Preventive Services Task Force
2014	Agency for Healthcare Research and Quality (AHRQ)	Screening for gonorrhea and chlamydia: systematic review to update the U.S. Preventive Services Task Force Recommendations
2014	Agency for Healthcare Research and Quality (AHRQ)	Medication therapy management interventions in outpatient settings
2014	Agency for Healthcare Research and Quality (AHRQ)	Imaging techniques for the diagnosis and staging of hepatocellular carcinoma
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Bevacizumab (Avastin®) as maintenance therapy after first progression on bevacizumab for patients with advanced colorectal cancer
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Assessment – APPRAISAL – Decision: (Good) Practice examples and recommendations
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Ibrutinib (Imbruvica®) for relapsed or refractory CLL
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Bevacizumab (Avastin®) for platinum-resistant recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Re-orientation of the Austrian parent-child preventive care programme: from assessment to expert appraisal
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Procedural guidance for the systematic evaluation of biomarker tests
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Cost and budget impact analysis of an increase in day surgery for selected indications]
2014	NIHR Health Services and Delivery Research programme	Commissioning for long-term conditions: hearing the voice of and engaging users – a qualitative multiple case study
2014	NIHR Health Services and Delivery Research programme	Informing the development of NICE (National Institute for Health and Care Excellence) quality standards through secondary analysis of qualitative narrative interviews on patients' experiences
2014	Agency for Healthcare Research and Quality (AHRQ)	Pharmacokinetic/pharmacodynamic measures for guiding antibiotic treatment for hospital acquired pneumonia
2014	Agency for Healthcare Research and Quality (AHRQ)	Diagnosis and treatment of myalgic encephalomyelitis/chronic fatigue syndrome
2014	NIHR Health Services and Delivery Research programme	Responsiveness of primary care services: development of a patient-report measure – qualitative study and initial quantitative pilot testing
2014	NIHR Health Services and Delivery Research programme	A mixed-methods evaluation of transformational change in NHS North East
2014	NIHR Health Services and Delivery Research programme	Explaining variation in emergency admissions: a mixed-methods study of emergency and urgent care systems
2014	NIHR Health Services and Delivery Research programme	Variation in compulsory psychiatric inpatient admission in England: a cross-sectional, multilevel analysis
2014	NIHR Health Services and Delivery Research programme	Staff satisfaction and organisational performance: evidence from a longitudinal secondary analysis of the NHS staff survey and outcome data
2014	NIHR Health Services and Delivery Research programme	Specialist rehabilitation for people with Parkinson's disease in the community: a randomised controlled trial
2014	Blue Cross Blue Shield Association (BCBS)	Quantitative electroencephalography as a diagnostic aid for attention-deficit/hyperactivity disorder in children
2014	Blue Cross Blue Shield Association (BCBS)	Critical issues in robotic surgery
2014	Blue Cross Blue Shield Association (BCBS)	Gene expression profiling in women with lymph node‒negative breast cancer to select adjuvant chemotherapy
2014	Blue Cross Blue Shield Association (BCBS)	Percutaneous mitral valve repair
2014	Blue Cross Blue Shield Association (BCBS)	Intra-articular hyaluronic acid for osteoarthritis of the knee
2014	Blue Cross Blue Shield Association (BCBS)	Fecal DNA analysis for colorectal cancer screening
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Fluticasone furoate/vilanterol (as trifenatate) (Relvar® Ellipta®)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Velaglucerase alfa
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Emtricitabine/rilpivirine/tenofovir disoproxil (as fumarate) (Eviplera®)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Imatinib (Glivec®)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Eltrombopag (Revolade®)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Lipegfilgrastim (Lonquex®)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Delta-9-tetrahydrocannabinol/cannabidiol (Sativex®)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Fluticasone furoate/vilanterol (as trifenatate) (Relvar® Ellipta®)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Azithromycin (Zedbac®)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Aripiprazole monohydrate (Abilify Maintena®)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Dolutegravir (Tivicay®)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Paclitaxel albumin-bound nanoparticles (Abraxane®)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Certolizumab pegol (Cimzia®)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Bortezomib (Velcade®)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Certolizumab pegol (Cimzia®) [in combination with methotrexate]
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Alogliptin (Vipidia®)
2014	All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG)	Alogliptin/metformin (Vipdomet®)
2014	Belgian Health Care Knowledge Centre (KCE)	Caring for mothers and newborns after uncomplicated delivery: towards integrated postnatal care
2014	Belgian Health Care Knowledge Centre (KCE)	Management of autism in children and young people: a good clinical practice guideline
2014	NIHR Health Technology Assessment programme	The use of fenestrated and branched endovascular aneurysm repair for juxtarenal and thoracoabdominal aneurysms: a systematic review and cost-effectiveness analysis
2014	NIHR Health Services and Delivery Research programme	Organisational interventions to reduce length of stay in hospital: a rapid evidence assessment
2014	NIHR Health Services and Delivery Research programme	A rapid synthesis of the evidence on interventions supporting self-management for people with long-term conditions: PRISMS - Practical systematic RevIew of Self-Management Support for long-term conditions
2014	NIHR Health Services and Delivery Research programme	Reducing Care Utilisation through Self-management Interventions (RECURSIVE): a systematic review and meta-analysis
2014	NIHR Health Services and Delivery Research programme	Learning for the NHS on procurement and supply chain management: a rapid evidence assessment
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Review of positron emission tomography (PET) indications. Appropriate use criteria]
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Comparative effectiveness of conservative treatment of breast cancer with brachytherapy and external beam radiation]
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Efficacy and safety of hip resurfacing versus traditional total hip arthroplasty]
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Efficacy and safety laparoscopic hysterectomy and lymphadenectomy in endometrial cancer (update)]
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Usefulness of magnetic resonance imaging for the diagnosis of non-specific low back pain]
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Evaluation of efficiency of organizational models for stroke management (stroke units)]
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Surgery guided by imaging assessment: efficacy, safety and economic impact of intraoperative magnetic resonance imaging (update)]
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Economic evaluation of preimplantation genetic diagnosis (PGD) for screening]
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Assessment of effectiveness and safety of Cyberknife and Gamma knife radiosurgery in intra and extracraneal lesions' treatment (update)]
2014	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Cost effectiveness of different types of coronary stents which are used in patients with acute coronary syndrome (ACS)]
2014	NIHR Health Services and Delivery Research programme	A qualitative study of decision-making and safety in ambulance service transitions
2014	NIHR Public Health Research (PHR) programme	On the buses: a mixed-method evaluation of the impact of free bus travel for young people on the public health
2014	NIHR Public Health Research (PHR) programme	Crime, fear of crime and mental health: Synthesis of theory and systematic reviews of interventions and qualitative evidence
2014	Agency for Healthcare Research and Quality (AHRQ)	Decision aids for cancer screening and treatment
2014	Agency for Healthcare Research and Quality (AHRQ)	Therapies for clinically localized prostate cancer: update of a 2008 systematic review
2014	Agency for Healthcare Research and Quality (AHRQ)	Radiotherapy treatments for head and neck cancer update
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Portrait of the use of bisphosphonates and denosumab in patients aged 50 years or older with osteoporosis who are covered by the public prescription drug insurance program]
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Use of long-term left ventricular assist devices for advanced heart failure in Quebec from 2010 to 2012]
2014	Health Quality Ontario (HQO)	Arthroscopic debridement of the knee: OHTAC recommendation
2014	Health Quality Ontario (HQO)	End-of-life health care in Ontario: OHTAC recommendation
2014	Health Quality Ontario (HQO)	Arthroscopic debridement of the knee: an evidence update
2014	Health Quality Ontario (HQO)	Health care for people approaching the end of life: an evidentiary framework
2014	Health Quality Ontario (HQO)	Cardiopulmonary resuscitation in patients with terminal illness: an evidence-based analysis
2014	Health Quality Ontario (HQO)	The determinants of place of death: an evidence-based analysis
2014	Health Quality Ontario (HQO)	Educational intervention in end-of-life care: an evidence-based analysis
2014	Health Quality Ontario (HQO)	End-of-life care interventions: an economic analysis
2014	Health Quality Ontario (HQO)	Patient care planning discussions for patients at the end of life: an evidence-based analysis
2014	Health Quality Ontario (HQO)	Team-based models for end-of-life care: an evidence-based analysis